Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Silo Pharma (SILO) Gross Margin (2019 - 2025)

Silo Pharma's Gross Margin history spans 7 years, with the latest figure at 14.77% for Q3 2025.

  • For Q3 2025, Gross Margin fell 10667.0% year-over-year to 14.77%; the TTM value through Sep 2025 reached 65.24%, down 2667.0%, while the annual FY2024 figure was 91.9%, 0.0% changed from the prior year.
  • Gross Margin for Q3 2025 was 14.77% at Silo Pharma, down from 91.91% in the prior quarter.
  • Across five years, Gross Margin topped out at 91.91% in Q3 2022 and bottomed at 10101.22% in Q4 2021.
  • The 5-year median for Gross Margin is 91.9% (2022), against an average of 685.85%.
  • The largest annual shift saw Gross Margin crashed -954477bps in 2021 before it surged 1019312bps in 2022.
  • A 5-year view of Gross Margin shows it stood at 10101.22% in 2021, then skyrocketed by 101bps to 91.9% in 2022, then changed by 0bps to 91.9% in 2023, then changed by 0bps to 91.9% in 2024, then crashed by -116bps to 14.77% in 2025.
  • Per Business Quant, the three most recent readings for SILO's Gross Margin are 14.77% (Q3 2025), 91.91% (Q2 2025), and 91.9% (Q1 2025).